Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Kidney Institute, Seoul National University Medical Research Center, Seoul, Korea.
J Korean Med Sci. 2019 Jun 24;34(24):e173. doi: 10.3346/jkms.2019.34.e173.
D-penicillamine has been reported to cause antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis presenting as rapidly progressive glomerulonephritis or pulmonary-renal syndrome mostly in adults. We report a pediatric case of D-penicillamine induced ANCA-associated vasculitis that manifests as a pulmonary-renal syndrome with a mild renal manifestation. A 13-year-old girl who has been taking D-penicillamine for five years under the diagnosis of Wilson disease visited the emergency room because of hemoptysis and dyspnea. She had diffuse pulmonary hemorrhage, microscopic hematuria, and proteinuria. Myeloperoxidase ANCA was positive, and a renal biopsy revealed pauci-immune crescentic glomerulonephritis. Under the diagnosis of D-penicillamine-induced ANCA-associated vasculitis, D-penicillamine was switched to trientine, and the patient was treated with plasmapheresis, glucocorticoid, cyclophosphamide, and mycophenolate mofetil. Pulmonary hemorrhage improved rapidly followed by the disappearance of the hematuria and proteinuria five months later.
青霉胺已被报道可引起抗中性粒细胞胞质抗体(ANCA)相关性血管炎,主要发生于成人,表现为急进性肾小球肾炎或肺-肾综合征。我们报告了一例儿童青霉胺诱导的 ANCA 相关性血管炎病例,表现为肺-肾综合征伴轻度肾脏表现。一名 13 岁女孩因患威尔逊病已服用青霉胺 5 年,因咯血和呼吸困难就诊于急诊。她有弥漫性肺出血、镜下血尿和蛋白尿。髓过氧化物酶 ANCA 阳性,肾活检显示寡免疫性新月体肾小球肾炎。根据青霉胺诱导的 ANCA 相关性血管炎的诊断,将青霉胺换为曲恩汀,并采用血浆置换、糖皮质激素、环磷酰胺和霉酚酸酯进行治疗。五个月后,患者的肺出血迅速改善,血尿和蛋白尿消失。